Melhem Solh

6.6k citations
139 papers · 2.3k · 1 hit paper · h-index 27

Impact in

  • Hematology top 0.5%
    • Hematopoietic Stem Cell Transplantation
    • Acute Myeloid Leukemia Research
  • Oncology top 2%
    • CAR-T cell therapy research

Papers in

    • Hematopoietic Stem Cell Transplantation 56
    • Acute Myeloid Leukemia Research 23
    • Multiple Myeloma Research and Treatments 22
    • CAR-T cell therapy research 39

Melhem Solh

130 papers receiving 2.2k citations

Melhem Solh's Hit Papers

Loncastuximab tesirine in relapsed or refractory diffuse large B-cell lymphoma (LOTIS-2): a multicentre, open-label, single-arm, phase 2 trial 2021 · 284 citations
2840+1+3Years since publication50100150200250

Peers

Melhem Solh
Comparison fields: 5 of 81
  • Hematology 1.1k
  • Oncology 1.1k
  • Transplantation 91
  • Pathology and Forensic Medicine 463
  • Genetics 267
Replace Thomas J. Nevill with:
Thomas J. Nevill Canada
Muneer H. Abidi United States
Cynthia Aristei Italy
Aleksandr Lazaryan United States
Taiga Nishihori United States
Muhıt Özcan Türkiye
Edward Agura United States
Eefke Petersen Netherlands
Stig Lenhoff Sweden
Ho‐Jin Shin South Korea
Melhem Solh relative to Thomas J. Nevill Canada Thomas J. Nevill's profile →
Citations per field
00.5×10×15.5×
Thomas J. Nevill · 1×
Citations per year

Countries citing papers authored by Melhem Solh

Since Specialization
Citations

This map shows the geographic impact of Melhem Solh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melhem Solh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melhem Solh more than expected).

Fields of papers citing papers by Melhem Solh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melhem Solh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melhem Solh. The network helps show where Melhem Solh may publish in the future.

Co-authors

The 25 scholars most cited alongside Melhem Solh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Melhem Solh Line = papers co-authored together Melhem Solh links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 139 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Loncastuximab tesirine in relapsed or refractory diffuse large B-cell lymphoma (LOTIS-2): a multicentre, open-label, single-arm, phase 2 trial
Hit paper breakdown →
2021284
2 2020132
3 2015111
4 202385
5 201982
6 201575
7 201674
8 201867
9 201564
10 201859
11 201157
12 201649
13 202048
14 201443
15 202143
16 201638
17 201036
18 202234
19 202133
20 201831

About Melhem Solh

Melhem Solh is a scholar working on Hematology, Oncology, Immunology, Molecular Biology and Public Health, Environmental and Occupational Health, having authored 139 papers that have together received 2.3k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (56 papers), CAR-T cell therapy research (39 papers), Acute Myeloid Leukemia Research (23 papers), Multiple Myeloma Research and Treatments (22 papers), Acute Lymphoblastic Leukemia research (20 papers), Immune Cell Function and Interaction (15 papers), Lymphoma Diagnosis and Treatment (15 papers) and Chronic Lymphocytic Leukemia Research (14 papers). The work is most often cited by research in Hematology (1.1k citations), Oncology (1.1k citations), Transplantation (91 citations), Pathology and Forensic Medicine (463 citations) and Genetics (267 citations). Melhem Solh has collaborated with scholars based in United States, United Kingdom and Italy. Frequent co-authors include Asad Bashey, Lawrence E. Morris, Scott R. Solomon, H. Kent Holland, Mehdi Hamadani, Paolo F. Caimi, Kirit M. Ardeshna, Brad S. Kahl, Carmelo Carlo‐Stella and Stacey Brown. Their work appears in journals such as Blood, Biology of Blood and Marrow Transplantation, Journal of Clinical Oncology, Blood Advances and Transplantation and Cellular Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact